2002
DOI: 10.1016/s1471-4922(02)02386-3
|View full text |Cite
|
Sign up to set email alerts
|

New policies for using anthelmintics in high risk groups

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
69
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(69 citation statements)
references
References 6 publications
0
69
0
Order By: Relevance
“…9,10 Polyparasitic diseases due to overlapping soil-transmitted helminth (STH, hookworm, ascariasis, and trichuriasis) infections have a well-documented association with anemia and impaired growth. 7,11 As a result, current international World Health Organization (WHO)-endorsed efforts include early treatment of 2-to 5-year-old children with the antihelminthic drugs albendazole or mebendazole against STH to prevent anemia-related morbidity. [11][12][13] Crosssectional studies have also suggested synergism between Schistosoma and Plasmodium infections in risk for anemia.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…9,10 Polyparasitic diseases due to overlapping soil-transmitted helminth (STH, hookworm, ascariasis, and trichuriasis) infections have a well-documented association with anemia and impaired growth. 7,11 As a result, current international World Health Organization (WHO)-endorsed efforts include early treatment of 2-to 5-year-old children with the antihelminthic drugs albendazole or mebendazole against STH to prevent anemia-related morbidity. [11][12][13] Crosssectional studies have also suggested synergism between Schistosoma and Plasmodium infections in risk for anemia.…”
Section: Introductionmentioning
confidence: 99%
“…7,11 As a result, current international World Health Organization (WHO)-endorsed efforts include early treatment of 2-to 5-year-old children with the antihelminthic drugs albendazole or mebendazole against STH to prevent anemia-related morbidity. [11][12][13] Crosssectional studies have also suggested synergism between Schistosoma and Plasmodium infections in risk for anemia. 14 With more sensitive testing, there is greater evidence that Schistosoma infection begins in very early childhood.…”
Section: Introductionmentioning
confidence: 99%
“…8 These chronic helminth infections can thus persist and affect each subsequent pregnancy of an individual woman. 10 The effects of maternal malaria infection during pregnancy on the infant are well defined, and malaria contributes to as much as 20% of low birthweight (LBW) deliveries, 36% of preterm deliveries, and 70% of intrauterine growth retardation in malaria-endemic areas. 11,12 Furthermore, co-infection with malaria and helminths has been found to be an important factor in adverse birth outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…Lack of adverse outcomes in animal studies, reports from mass campaigns, and a randomized trial in Uganda of ivermectin and albendazole also support treating pregnant women. 9,10 A study in Nepal, where rates of hookworm infection in pregnant women were high, suggested an improvement in maternal anemia, birthweight, and infant mortality in the group of women receiving albendazole during pregnancy. 15 However, a subsequent randomized controlled trial in Uganda did not find a difference in birth outcomes in pregnant women treated with albendazole or praziquantel.…”
Section: Introductionmentioning
confidence: 99%
“…It also formed an Expert Committee to provide clear and strategic orientation on how to implement the recommendations (WHO 2002). A series of articles were published in internationally recognized periodicals systematizing the most recent technical and scientific information about the control of schistosomiasis and STH (Allen et al 2002a, b, 2005, Crompton et al 2003, Olds 2003, Richter 2003, Colley & Sear 2004.…”
mentioning
confidence: 99%